Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide)

Many patients pay $0 through manufacturer patient assistance programs. Contact our pharmacists — we handle all the paperwork.

Odefsey is a complete single-tablet regimen for adults and adolescents with HIV-1 who have no antiretroviral treatment history and a viral load ?100,000 copies/mL, or who are virologically stable on an antiretroviral regimen. Taken once daily with a meal.

Odefsey combines emtricitabine, rilpivirine, and tenofovir alafenamide — providing a regimen with a low pill burden and the favorable safety profile of TAF.

• Complete once-daily regimen
• TAF-based — improved bone and renal safety
• Taken with a meal
• Refill reminders available